CN1170592C - 美拉加林的新用途 - Google Patents

美拉加林的新用途 Download PDF

Info

Publication number
CN1170592C
CN1170592C CNB008027935A CN00802793A CN1170592C CN 1170592 C CN1170592 C CN 1170592C CN B008027935 A CNB008027935 A CN B008027935A CN 00802793 A CN00802793 A CN 00802793A CN 1170592 C CN1170592 C CN 1170592C
Authority
CN
China
Prior art keywords
pab
melagatran
prodrug
inflammation
aze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008027935A
Other languages
English (en)
Chinese (zh)
Other versions
CN1341028A (zh
Inventor
I
I·基尔克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1341028A publication Critical patent/CN1341028A/zh
Application granted granted Critical
Publication of CN1170592C publication Critical patent/CN1170592C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
CNB008027935A 1999-01-13 2000-01-13 美拉加林的新用途 Expired - Fee Related CN1170592C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use
SE99000705 1999-01-13

Publications (2)

Publication Number Publication Date
CN1341028A CN1341028A (zh) 2002-03-20
CN1170592C true CN1170592C (zh) 2004-10-13

Family

ID=20414074

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008027935A Expired - Fee Related CN1170592C (zh) 1999-01-13 2000-01-13 美拉加林的新用途

Country Status (20)

Country Link
US (3) US6683054B1 (enExample)
EP (1) EP1150704B1 (enExample)
JP (1) JP2002534477A (enExample)
KR (1) KR100701539B1 (enExample)
CN (1) CN1170592C (enExample)
AT (1) ATE319473T1 (enExample)
AU (1) AU767077B2 (enExample)
BR (1) BR0007452A (enExample)
CA (1) CA2356611A1 (enExample)
CY (1) CY1107465T1 (enExample)
DE (1) DE60026491T2 (enExample)
DK (1) DK1150704T3 (enExample)
ES (1) ES2257282T3 (enExample)
IL (1) IL143985A0 (enExample)
NO (1) NO20013414D0 (enExample)
NZ (1) NZ512713A (enExample)
PT (1) PT1150704E (enExample)
SE (1) SE9900070D0 (enExample)
WO (1) WO2000041716A1 (enExample)
ZA (1) ZA200105275B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis
SE0103590D0 (sv) * 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0200198D0 (sv) * 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
EP2560966B1 (en) 2010-03-30 2021-01-06 Verseon International Corporation Multisubstituted aromatic compounds as inhibitors of thrombin
EP2970141B1 (en) 2013-03-15 2020-02-26 Verseon Corporation Halogenopyrazoles as inhibitors of thrombin
CN110101699A (zh) 2013-03-15 2019-08-09 维颂公司 作为丝氨酸蛋白酶抑制剂的多取代芳族化合物
CN106687445A (zh) 2014-09-17 2017-05-17 维颂公司 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物
KR102824411B1 (ko) 2015-02-27 2025-06-23 베르선 코포레이션 세린 프로테아제 저해제로서의 치환된 피라졸 화합물
SG11202100247WA (en) 2018-07-13 2021-02-25 Verseon Int Corporation Thrombin inhibitors, formulations, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
TW541316B (en) * 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US5669754A (en) * 1996-04-22 1997-09-23 Advanced Dynamics Corporation Ltd. Method and apparatus for collecting plates
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
JP2002525298A (ja) 1998-09-28 2002-08-13 メルク エンド カムパニー インコーポレーテッド トロンビン阻害剤の投与による炎症疾患の処置法
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
KR20010101492A (ko) 2001-11-14
ATE319473T1 (de) 2006-03-15
DE60026491T2 (de) 2006-11-02
CY1107465T1 (el) 2012-12-19
BR0007452A (pt) 2001-10-16
WO2000041716A1 (en) 2000-07-20
IL143985A0 (en) 2002-04-21
PT1150704E (pt) 2006-06-30
DK1150704T3 (da) 2006-06-12
US20080058303A1 (en) 2008-03-06
NZ512713A (en) 2004-10-29
US20040082518A1 (en) 2004-04-29
DE60026491D1 (de) 2006-05-04
AU2336100A (en) 2000-08-01
EP1150704B1 (en) 2006-03-08
AU767077B2 (en) 2003-10-30
EP1150704A1 (en) 2001-11-07
CA2356611A1 (en) 2000-07-20
CN1341028A (zh) 2002-03-20
NO20013414L (no) 2001-07-10
US6683054B1 (en) 2004-01-27
JP2002534477A (ja) 2002-10-15
ES2257282T3 (es) 2006-08-01
KR100701539B1 (ko) 2007-03-30
SE9900070D0 (sv) 1999-01-13
NO20013414D0 (no) 2001-07-10
ZA200105275B (en) 2002-09-26

Similar Documents

Publication Publication Date Title
US20080058303A1 (en) Use of melagatran
JPWO1999059634A1 (ja) 抗炎症点眼剤
CN102573831A (zh) 用于治疗免疫相关病症的去铁胺-金属络合物
WO2019209738A1 (en) Use of neutrophil elastase inhibitors in liver disease
CN1146416C (zh) H+、k+-腺苷三磷酸酶抑制剂在制备治疗鼻息肉药物中的用途
JP2010510257A (ja) 喘息及びアレルギー性鼻炎の治療におけるアルギナーゼ阻害剤の使用
CN115006532A (zh) 蛋白酶体抑制剂的应用
CN113613640B (zh) 肾上腺素能β2受体激动剂R-对映体在治疗炎症性肠病及其肠外疾病的新应用
TW200306811A (en) Medicinal compositions for inhibiting tryptase
NL2025730B1 (en) Compounds for treatment of sepsis
JPH03236330A (ja) 炎症治療剤
JP2006507323A (ja) トロンビン阻害剤メラガトランを含む水性医薬製剤、および血栓塞栓症の処置において経鼻投与に使用するための医薬の製造における該製剤の使用。
JP2003513048A (ja) 気道狭窄の治療のための酸化窒素の使用
MXPA01007003A (es) Nuevo uso del melagatran
CN114392257A (zh) 血竭素高氯酸盐的医药用途
JP2004529962A (ja) 低分子量トロンビン阻害剤の新規使用
JP2004527529A (ja) 急性腎不全を予防するための方法
CN1678307A (zh) 通过选择性磷酸二酯酶4抑制剂来治疗非过敏性鼻炎
AU2002305989A1 (en) The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
HK1036412B (en) Anti-inflammatory eye drops
WO2004087147A1 (ja) 肺疾患の治療および/または予防剤
HK1026145B (en) A composition for the treatment of irds and ards
HK1026145A1 (en) A composition for the treatment of irds and ards
MXPA01000561A (en) Therapeutic agents for allergic diseases
HK1036412A1 (en) Anti-inflammatory eye drops

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041013

Termination date: 20110113